99 Episoder

  1. Molecular signatures of glioma causation

    Publisert: 6.8.2021
  2. Testing methods for MGMT promoter methylation

    Publisert: 23.7.2021
  3. Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas

    Publisert: 9.7.2021
  4. Posterior fossa syndrome

    Publisert: 18.6.2021
  5. Loss of H3K27me3 in meningiomas

    Publisert: 4.6.2021
  6. Loss of H3K27me3 in the Tübingen meningioma cohort

    Publisert: 21.5.2021
  7. A prospective phase II randomized trial of proton radiotherapy vs intensity modulated radiotherapy for patients with newly diagnosed GBM

    Publisert: 7.5.2021
  8. Brain radiotherapy and decline in fine motor skills

    Publisert: 9.4.2021
  9. A serum based DNA methylation assay to detect gliomas

    Publisert: 26.3.2021
  10. PTEN deficiency and proteosome addiction in glioblastoma

    Publisert: 12.3.2021
  11. Cold-Inducible RNA-Binding Protein expression and recurrence of brain metastases

    Publisert: 26.2.2021
  12. The incidence of brain metastases among patients with metastatic breast cancer

    Publisert: 12.2.2021
  13. Epidemiology of Brainstem High-Grade Gliomas in Children and Adolescents in the United States, 2000-2017

    Publisert: 29.1.2021
  14. A large longitudinal study of patients with Neurofibromatosis Type 2.

    Publisert: 15.1.2021
  15. Vorinostat and bevacizumab for recurrent glioblastoma

    Publisert: 1.1.2021
  16. A subset of pediatric thalamic gliomas

    Publisert: 18.12.2020
  17. Supratotal resection of lower-grade gliomas

    Publisert: 4.12.2020
  18. Friends of SNO

    Publisert: 20.11.2020
  19. Announcing Neuro-Oncology: The Podcast

    Publisert: 19.11.2020

5 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site